HEAL Rapport du Comité

1.

Santé Canada apporte les modifications qui s’imposent au Programme d’accès spécial afin

a)

que les coûts qui constituent un fardeau indu pour un patient soient assumés par le gouvernement fédéral et

b)

que le fardeau bureaucratique soit réduit;

2.

Santé Canada fasse chaque année rapport au Comité permanent de la santé, par l’entremise de la Chambre des communes, sur la situation des insulines animales et de l’insuline humaine recombinée;

3.

Health Canada request significant advance notice from Eli Lilly, (for example, five years), on any change in the company’s policy regarding the provision of animal-sourced insulins;

4.

Health Canada, in partnership with the Canadian Food Inspection Agency, facilitate the work done by Eli Lilly through active support for various measures, including the provision of tissue for insulin purification through the relationship established between the Agency and the abattoirs;

5.

Health Canada work closely with the Food and Drug Administration of the United States such that a concerted strategy is developed to ensure a North American supply of animal-sourced insulins; and

6.

Health Canada work closely with the Canadian Medical Association, the Royal College of Physicians and Surgeons of Canada and other professional bodies to ensure that the use of animal-sourced insulins is an option considered in the education and subsequent practice of physicians.